Why the study?
Do lifestyle changes, antiobesity agents, and bariatric surgery reduce serological markers of inflammation in overweight and obese patients?
Do lifestyle changes, antiobesity agents, and bariatric surgery reduce serological markers of inflammation in overweight and obese patients?
Weight loss interventions including lifestyle changes, antiobesity agents, and bariatric surgery are associated with decreased serological inflammatory markers in overweight and obese patients.
Answers are grounded in this paper and cite their sources.
Supports reduced inflammation with weight loss in obesity; hypothesis-generating and should not yet change practice.
Overweight and obesity are highly prevalent in developed countries and are also becoming more frequent in the developing world. Overweight and obese patients have elevated levels of several inflammatory markers and this inflammatory state might contribute to their increased vascular risk. We summarize the effects of lifestyle changes, antiobesity agents, and bariatric surgery on serological inflammatory markers in overweight and obese patients. Most studies showed a decrease in inflammation with all 3 interventions. However, it remains to be established whether the decrease in inflammatory markers induced by lifestyle changes or (where indicated) with antiobesity agents or bariatric surgery will translate into reduced vascular morbidity and mortality in overweight and obese patients.
No takes yet. Share an insight, caveat, or question.
Τζιόμαλος et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: